Marijke Reynders - Concepedia

Author

Marijke Reynders

Also Known As

Barney Potter, Geert Vanheule, M REYNDERS, M Reynders, M. REYNDERS, M. Reynders, Marc Bourgeois, Marie-Astrid Vernet, Marijke B.M.L. Reynders, Marijke BML Reynders

168

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

AZ Sint-Jan KU Leuven Ghent University Hospital Rega Institute for Medical Research Ghent University

About

Marijke Reynders is an author at AZ Sint-Jan specializing in medicine, epidemiology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	1.2K
2	Public Health	4	4	180
3	Health Sciences	2	2	53
4	Natural Sciences	1	1	17
5	Allergy	1	1	70

Marijke Reynders

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, Clinical Microbiology and Infection	2021	219
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1 Nico Janssen, Rémy Nyga, Lore Vanderbeke, Emerging infectious diseases Covid-19–associated Pulmonary Aspergillosis1Clinical EpidemiologySeveral FactorsRespiratory InfectionInfectious Respiratory Disease	2021	136
EFFICACY OF HEAT-INACTIVATED HEPATITIS B VACCINE IN HAEMODIALYSIS PATIENTS AND STAFF Jan Desmyter, Guy De Groote, J. Colaert, The Lancet VaccinationHemodialysisViral HepatitisHepatitis BHepatitis	1983	121
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study Jens Van Praet, Marijke Reynders, Dirk De Bacquer, Journal of the American Society of Nephrology	2021	94
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial Lore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans, Intensive Care Medicine Proof-of-concept TrialAntifungal AgentIll Influenza PatientsInvasive Pulmonary AspergillosisRespiratory Infection	2021	91
Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021 Kimberley Benschop, Jan Albert, Andrés Antón, Eurosurveillance	2021	86
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria Ingrid Wybo, Denis Piérard, Inge Verschraegen, Journal of Antimicrobial Chemotherapy	2006	73
Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study Toine Mercier, Albert Dunbar, Elizabeth de Kort, Medical Mycology Diagnostic MycologyTranslational MedicineLateral Flow AssaysAllergyFungal Pathogen	2019	70
Topical treatment of CIN 2+ by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study C. Van Pachterbeke, Dario Bucella, Serge Rozenberg, Gynecologic Oncology PharmacologyAntiviral TherapyTopical DrugPharmacotherapyDermatology	2009	67
Evolution, geographic spreading, and demographic distribution of Enterovirus D68 Emma B. Hodcroft, Robert Dyrdak, Cristina Andrés, PLoS Pathogens Molecular Diagnostic TechniquesViral EvolutionEmerging Infectious DiseasesEnterovirus D68Medicine	2022	60

Page 1